Sonova AG
90
2
2
75
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.6%
5 terminated/withdrawn out of 90 trials
93.8%
+7.2% vs industry average
0%
0 trials in Phase 3/4
41%
31 of 75 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (90)
Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
Role: lead
Remote Microphone Performance Comparison in Adults With Hearing Loss
Role: lead
The Mental Cost and Burden of Listening
Role: collaborator
Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
Role: lead
fNIRS, Listening Effort, and Motivation
Role: lead
Speech Locator In-car Performance Evaluation
Role: lead
Compression Headphone Study
Role: lead
Speech Understanding and Listening Effort Benefits of Hearing Instruments
Role: lead
Evaluation of BiCROS Fitting Benefits
Role: lead
Assessing Speech Perception and Amplification Benefit During Infancy
Role: collaborator
A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
Role: lead
Clinical Study of Released Unitron RIC and BTE Hearing Aid Models
Role: lead
Venting Effects on Speech Performance
Role: lead
Effects of Short-term Choir Participation on Auditory Perception in Hearing-aided Older Adults.
Role: collaborator
Lab Evaluation of Novel Hearing Aid Coupling Method
Role: lead
Investigating Hearing Aid Frequency Response Curves
Role: lead
Investigating Hearing Aid Frequency Response Curves 2
Role: lead
A Pediatric Comparison of Remote Microphone Technologies
Role: lead
Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss
Role: lead
Evaluation of Investigational Hearing Instrument Features
Role: lead